| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 3.716 | 4.826 | 4.758 | 3.757 | 3.621 | 2.086 | 6.632 |
| Total Income - EUR | - | - | - | 3.716 | 4.826 | 4.764 | 3.757 | 3.621 | 2.086 | 6.632 |
| Total Expenses - EUR | - | - | - | 2.129 | 3.359 | 2.769 | 2.175 | 4.704 | 1.944 | 2.290 |
| Gross Profit/Loss - EUR | - | - | - | 1.588 | 1.467 | 1.995 | 1.582 | -1.083 | 143 | 4.342 |
| Net Profit/Loss - EUR | - | - | - | 1.476 | 1.322 | 1.852 | 1.469 | -1.192 | -38 | 3.616 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Anomis Med Anest Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 2.939 | 1.446 | 3.875 | 3.743 | 1.337 | 503 | 3.180 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 0 | 0 | 476 | 55 | 141 |
| Cash | - | - | - | 2.939 | 1.446 | 3.875 | 3.743 | 862 | 448 | 3.040 |
| Shareholders Funds | - | - | - | 1.519 | 1.373 | 1.902 | 1.517 | -1.144 | -1.178 | 2.444 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 1.420 | 73 | 1.973 | 2.226 | 2.481 | 1.682 | 736 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Anomis Med Anest Srl